AC
TMO icon

Annandale Capital’s Thermo Fisher Scientific TMO Stock Holding History

Annandale Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
5,452
+1,000
+22% +$480K 0.37% 52
2026
Q1 		$2.19M Buy
4,452
+1,004
+29% +$545K 0.31% 60
2025
Q4 		$2M Hold
3,448
– – 0.24% 65
2025
Q3 		$1.67M Buy
3,448
+1,121
+48% +$522K 0.28% 63
2025
Q2 		$944K Buy
+2,327
New +$973K 0.07% 76

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Annandale Capital's TMO Position: Q2 2026 in Review

Annandale Capital increased its Thermo Fisher Scientific (TMO) stake by 22% in Q2 2026, buying an estimated $480K and bringing the position to 5,452 shares worth $2.73M. The position accounts for 0.37% of the portfolio, ranked #52.

Annandale Capital first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Annandale Capital held 5,452 shares of Thermo Fisher Scientific worth $2.73M as of Q2 2026.
  • Annandale Capital bought 1,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $480K.
  • Thermo Fisher Scientific made up 0.37% of Annandale Capital's portfolio in Q2 2026, its #52 holding.
  • Annandale Capital first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Annandale Capital's 13F filing for Q2 2026, filed 13 Aug 2026.